New partnerships and further development of existing partnerships between clinical services, academia, industry and patients and the public are essential in order to realise the benefits of genomics for precision medicine in Wales.
We anticipate that strong, effective partnerships will speed up change, accelerate adoption and drive up quality outcomes for patients.
Our partners support us in the advancement of life sciences in Wales and enable shared risk and decision making to achieve the five ‘P’s of precision medicine: prediction and prevention of disease; more precise diagnoses; targeted personalised interventions; and a more participatory role for patients.